SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAPUTO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.599
AS - Asia 4.401
EU - Europa 4.039
SA - Sud America 736
AF - Africa 83
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.444
SG - Singapore 1.892
PL - Polonia 1.755
CN - Cina 1.233
BR - Brasile 619
IT - Italia 560
UA - Ucraina 435
DE - Germania 430
HK - Hong Kong 416
TR - Turchia 308
VN - Vietnam 266
GB - Regno Unito 248
RU - Federazione Russa 139
FI - Finlandia 111
SE - Svezia 108
ID - Indonesia 78
CA - Canada 75
MX - Messico 68
AR - Argentina 60
FR - Francia 59
IN - India 54
NL - Olanda 49
ZA - Sudafrica 36
BE - Belgio 35
AT - Austria 26
BD - Bangladesh 25
IQ - Iraq 25
EC - Ecuador 21
JP - Giappone 21
LT - Lituania 19
ES - Italia 18
CZ - Repubblica Ceca 15
RO - Romania 11
CO - Colombia 10
IR - Iran 10
KE - Kenya 10
MA - Marocco 10
PK - Pakistan 9
IL - Israele 8
TN - Tunisia 8
VE - Venezuela 8
EG - Egitto 7
PY - Paraguay 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
IE - Irlanda 6
JO - Giordania 6
KZ - Kazakistan 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 4
LB - Libano 4
OM - Oman 4
PE - Perù 4
AL - Albania 3
CL - Cile 3
JM - Giamaica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
GT - Guatemala 2
KH - Cambogia 2
KR - Corea 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
NO - Norvegia 1
NP - Nepal 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
Totale 17.869
Salva come PNG Salva come JPEG
Città #
Warsaw 1.752
Singapore 1.009
Fairfield 948
Ashburn 889
Woodbridge 759
Houston 557
Beijing 462
Santa Clara 432
Hong Kong 415
Jacksonville 401
Seattle 378
Chandler 369
Wilmington 344
Ann Arbor 342
Cambridge 328
Izmir 237
Ferrara 205
Princeton 173
New York 163
Nanjing 161
Dallas 135
Los Angeles 133
San Diego 107
The Dalles 106
Munich 95
Ho Chi Minh City 74
Milan 70
Shanghai 64
Jakarta 57
Hanoi 52
São Paulo 50
Bologna 44
Boardman 42
Mexico City 42
London 41
Nanchang 41
Shenyang 37
Tianjin 37
Hebei 36
Brussels 35
Dong Ket 34
Buffalo 33
Jiaxing 33
Chicago 31
Montreal 30
Brooklyn 29
Rome 29
Changsha 28
Dearborn 27
Nuremberg 25
Rio de Janeiro 25
Turku 25
Boston 24
Falls Church 24
San Francisco 24
Hefei 23
Phoenix 23
Council Bluffs 22
Norwalk 22
Falkenstein 21
Jinan 21
Mountain View 21
San Jose 21
Stockholm 21
Tokyo 21
Orem 20
Belo Horizonte 19
Helsinki 19
Atlanta 18
Chennai 18
Moscow 18
Orange 18
Poplar 17
Redwood City 17
Amsterdam 16
Johannesburg 16
Manchester 16
Denver 15
Kunming 15
Porto Alegre 15
San Mateo 15
Toronto 15
Da Nang 14
Modena 14
Frankfurt am Main 13
Auburn Hills 12
Brno 12
Des Moines 12
Ningbo 12
Haiphong 11
Ottawa 11
Ankara 10
Goiânia 10
Taizhou 10
Washington 10
Augusta 9
Brasília 9
Ferrara di Monte Baldo 9
Salt Lake City 9
Baghdad 8
Totale 12.741
Salva come PNG Salva come JPEG
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 345
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 321
BK virus-plasmid expression vector that persists episomally in human cells and shuttles into Escherichia coli 305
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS tat-based vaccines 277
Candidate HIV-1 Tat vaccine development: From basic science to clinical trials 272
HIV-1 tat addresses dendritic cells to induce a predominant th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 248
The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: Findings in a cohort of HIV-1 seroconverters 245
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys 239
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 235
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 234
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 226
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 223
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 216
Nanoparticles for delivery of a pharmacologically active agent 202
Recombinant herpes simplex virus and uses therefor 200
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 188
null 183
null 179
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 175
Episomal DNA of a BK virus variant in a human insulinoma 169
Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors and dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice 168
null 167
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 166
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 166
Containment of infection in Tat vaccinated monkeys after rechallenge with a higher dose of SHIV89.6Pcy243 165
Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients 163
Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model 161
T.P.2.07 The systemic administration of a low dose of 2OMePS-AON combined with novel cationic polymethylmethacrylate nanoparticles induces the rescue of dystrophin expression in the mdx murine model 161
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 160
Transformation of hamster kidney cells by fragments of BK virus DNA 160
Cooperation in oncogenesis between BK virus early region gene and the activated human c-Harvey RAS oncogene 158
Transformation of human embryonic fibroblasts by BK virus, BK virus DNA and a subgenomic BK virus DNA fragment 154
Adenovirus type 12 early region 1A proteins repress class I HLA expression in transformed human cells 149
Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane 148
EFFECT OF TAT TRANSDOMINANT NEGATIVE MUTANTS ON HIV-1 REPLICATION IN JURKAT T-CELL LINES 146
Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery 144
Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region 139
The tat gene and protein of the human immunodeficiency virus type 1. 136
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 135
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 135
DNA immunization with HIV-1 tat mutated in the transactivation domain induces humoral and cellular immune response against wild-type Tat 134
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 132
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 132
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells 131
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 129
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein 127
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 125
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 123
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 122
The HIV-1 tat gene as a target for gene therapy and analysis of its role in cell proliferation 121
Induction of anti-Tat immune response in mice following inoculation of plasmid DNA expressing HIV-tat mutant genes. 117
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 117
Reexamination of the coding potential of the HTLV-1 pX region 117
Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination 117
The HIV-1 regulatory genes tat and rev as targets for gene therapy 115
Induzione di una risposta immune in topi immunizzati con DNA plasmidici codificanti due mutanti transdominanti negativi del gene tat di HIV-1. 115
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles 115
Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens 115
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 114
null 113
Nanoparticle-Mediated Delivery of Antisense Oligoribonucleotides Allows Restoration of Dystrophin Expression in the mdx Mouse 112
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) 112
null 110
Co-operation in cell transformation between BK virus and the human c-Harvey-ras oncogene 110
In Chronic Hepatitis C Infection, Myeloid-Derived Suppressor Cell Accumulation and T Cell Dysfunctions Revert Partially and Late After Successful Direct-Acting Antiviral Treatment 110
Presenza del virus BK in sarcomi di Kaposi. 108
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 108
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 108
Inhibition of HIV-1 tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity 107
Formation of oligomeric free BK virus DNA is required for tandem integration of viral genomes into cellular DNA 105
null 104
The Sp1 transcription factor does not directly interact with the HIV-1 Tat protein 104
Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells 104
null 103
Expression of hepatitis B surface antigen in human cells by a recombinant BK virus DNA vector 103
New BK virus episomal vector for complementary DNA expression in human cells 103
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 103
Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application 102
Functional polymeric nano/microparticles for surface adsorption and delivery of protein and DNA vaccines 102
null 101
Constitutive expression of hiv-1 tat protein in human jurkat t cells using a bk virus vector 100
Antiretroviral Therapy Partially Restores Phenotypic and Metabolic Immunosenescence Features of T Cells in Hiv Infected Individuals 99
Core-shell microspheres by dispersion polymerization as promising delivery systems for proteins 99
Transformation of hamster kidney cells by a fragment of BK virus DNA containing the entire early region 98
HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials 98
Vaccines containing the HIV tat protein as an adjuvant for the enhancement of cytotoxic T-cell responses 98
The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells 97
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 97
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 97
Interaction of Sp1 transcription factor with HIV-1 Tat protein: Looking for cellular partners 97
Induction of malignant subcutaneous sarcomas in hamsters by a recombinant DNA containing BK virus early region and the activated human c-Harvey-ras oncogene 96
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 96
null 95
Pentosan Polysulfate as an Inhibitor of Extracellular HIV-1 Tat 95
null 94
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules 93
Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication 93
The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice 93
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 93
null 91
Totale 14.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.960
Totale 91.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.043 0 0 0 0 0 153 109 219 72 237 157 96
2021/20221.319 38 111 73 82 29 53 68 114 61 115 106 469
2022/2023933 140 37 54 103 130 118 59 97 113 9 47 26
2023/2024644 63 80 33 23 44 143 25 36 20 17 11 149
2024/20252.923 91 70 240 100 332 225 114 108 460 405 469 309
2025/20264.415 840 313 746 1.014 1.095 407 0 0 0 0 0 0
Totale 18.117